article thumbnail

Union Budget 2025-26: A roadmap for India’s pharmaceutical leadership

Express Pharma

The Union Budget 2025-26 represents an opportunity for India to recalibrate policies that will drive the pharmaceutical sector forward as it approaches significant economic and industrial growth. India’s pharmaceutical industry is poised for transformative growth thanks to its ability to supply affordable medicines worldwide.

article thumbnail

JP Nadda inaugurates Jan Aushadhi Diwas celebrations

Express Pharma

Union Minister of Chemicals and Fertilizers, and Health and Family Welfare, Jagat Prakash Nadda inaugurated the weeklong celebrations of Jan Aushadhi Diwas, 2025 by flagging off the Rath (Chariot) and 10 other vehicles carrying the information about Pradhan Mantri Bhartiya Janaushadhi Pariyojana from Nirman Bhawan. to the citizens.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Govt provides update on schemes implemented in the pharma sector

Express Pharma

It incentivises production of high-value medicines such as biopharmaceuticals, complex generic drugs, patented drugs or drugs nearing patent expiry, auto-immune drugs, anti-cancer drugs, etc., As of March 2025, the committed investment of ₹3,938.5 The scheme has enabled enhanced investment and production in eligible products.

article thumbnail

CHMP meeting highlights – May 2025

European Pharmaceutical Review

Generic medicine Emtricitabine/Tenofovir alafenamide Viatris (emtricitabine / tenofovir alafenamide), received a positive opinion to treat adults and adolescents with human immunodeficiency virus type 1 (HIV-1). The post CHMP meeting highlights – May 2025 appeared first on European Pharmaceutical Review.

article thumbnail

9th Advanced GMP Workshop 2024 was organised by IPA

Express Pharma

IPA leadership is committed to strengthening operational capabilities and ensuring that patients worldwide have access to affordable and quality-assured medicines.” It’s not just a goal; it is the foundation of our global leadership, and the trust placed in us.

article thumbnail

Addressing US FDA challenges in Indian sterile drug manufacturing – Part 1

Express Pharma

Indian pharmaceutical companies supply more than 60 per cent of global demand for vaccines and over 40 per cent of generic medicines consumed in the United States (2). Shift towards unannounced inspections: In a press release dated May 6, 2025, the U.S. Source: Ministry of Commerce & Industry, DGCI&S, 2025 4.

article thumbnail

US tariffs leave Indian pharma unaffected, industry voices relief

Express Pharma

US President Donald Trump announced new tariffs on April 2, 2025, as part of his Liberation Day economic plan. healthcare by ensuring a steady supply of affordable medicines. The decision underscores the critical role of cost-effective, life-saving generic medicines in public health, economic stability, and national security.